Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01304082 · ClinicalTrials.gov registry record · NA

Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.

A NA study, sponsored by Massachusetts General Hospital.

Terminated
Registry status
NA
Development phase
29
Enrollment target

NCT01304082: Clinical Trial NA study, sponsored by Massachusetts General Hospital.

NCT01304082 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01304082, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

When one receives a local anesthetic, such as novocaine for a dental procedure, there is a burning painful sensation experienced upon injection of the local anesthetic. We are trying to understand the role of pH (how acidic a solution is) in the production of pain during local anesthetic administration. We hypothesize that less acidic solutions produce less burning. We also want to determine whether or not the pH of the solution affects the rate of onset of the local anesthesia. We will recruit subjects from patients who have a clinical indication for lumbar medial branch (LMB) nerve blocks, procedures frequently performed at the Massachusetts General Hospital Center for Pain Medicine. For each patient, three nerve blocks are administered at adjacent spinal levels, typically using either lidocaine or bicarbonate-buffered lidocaine as the local anesthetic. We will add a saline control as part of the research procedure and then provide lidocaine at the control location before continuing with the nerve blocks. This clinical procedure offers an ideal opportunity to compare the effects of the three solutions. There will be almost no deviation from the standard clinical procedure. After the injection of each solution, the pain score on administration of the medication will be recorded immediately. We will also provide a continuous stimulation (pin taps) after the local anesthetic injection and record when the patient experiences hypoesthesia (reduced sensation) and anesthesia (absent sensation). Finally, we will record the pain score upon reinsertion of a needle to mark the precise location (part of the clinical procedure) one minute after the local anesthetic injection. All data will be collected during the a single clinical visit. The study will conclude when 60 subjects have successfully been tested. Data will be reviewed annually.

Primary Outcome

Pain score upon injection of local anesthetic: the pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).

Interventions

  • DRUG Lidocaine
  • DRUG normal saline
  • DRUG alkalinized lidocaine

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2011-01
Est. Completion 2014-11
Phase NA
Massachusetts General Hospital

2,032 total trials

Why NCT01304082 stopped before completion

NCT01304082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Lidocaine is the first listed.

NCT01304082 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01304082 about?

NCT01304082 is a clinical study titled "Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.". When one receives a local anesthetic, such as novocaine for a dental procedure, there is a burning painful sensation experienced upon injection of the local anesthetic. We are trying to understand the role of pH (how acidic a solution is) in the production of pain during local anesthetic administrat...

What is the current status of trial NCT01304082?

This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2011-01. Estimated completion is 2014-11.

What interventions are being tested in trial NCT01304082?

The interventions under investigation include: Lidocaine (DRUG), normal saline (DRUG), alkalinized lidocaine (DRUG).

Who is sponsoring clinical trial NCT01304082?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01304082's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01304082, the US trial registry maintained by the National Library of Medicine. NCT01304082 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.